Business1 year ago
Bayer’s shares drop 20% to lowest level since 2009 due to drug development and Roundup trial setback
In a severe blow, Bayer AG suffered its largest market value drop due to setbacks with a new anti-clotting drug and a hefty $1.5 billion fine...
